Tuberculosis, a disease with a history stretching back nearly 9000 years, has left an indelible mark on humanity. From ancient civilizations to modern societies, its presence has persisted, defying attempts at eradication. In India, the story of TB spans over 3300 years, a proof of its enduring grip on the nation and the world. Unlike diseases such as polio and smallpox, TB has proven resilient, evading total eradication despite centuries of medical advancement.

A key characteristic of TB is its transmissibility, facilitated by its airborne nature. Consequently, any strategy to combat TB must transcend national boundaries, necessitating a coordinated global effort. In recent decades, the United Nations has spearheaded initiatives to address the global TB burden, recognizing the urgent need for collective action.

Globally, TB remains a formidable challenge, with approximately 10.6 million cases reported annually. Men bear a disproportionate burden, accounting for 5.8 million of these cases. India, home to a significant portion of the global TB burden, witnesses approximately 15-1700 TB-related deaths daily, contributing to 27-28% of the global TB burden.

The impact of TB extends beyond health, adversely affecting human resource development, productivity, and overall well-being. Poverty and social inequality exacerbate the TB crisis, with marginalized communities bearing the brunt of the disease. In India, TB has long been associated with poverty, earning the moniker of “the disease of the poor.” The prevalence of TB in rural areas is testament to the complex interplay between social determinants of health and disease transmission. During my time in the army, I observed that TB cases primarily afflicted jawans from rural pockets, while no officer was ever reported to have contracted the disease.

Environmental factors, including pollution and poor urban planning, further exacerbate the spread of TB. Overcrowded living conditions, such as those found in Mumbai’s chawls, provide fertile ground for TB transmission, highlighting the interconnectedness of urban development and public health.

A poignant historical example illustrating the impact of the environment on TB is the case of Subhash Chandra Bose. When, in 1952, Bose contracted TB, he was relocated to Dalhousie, where he resided in an isolated area atop a hill. Remarkably, his recovery, achieved without the need for antibiotics over a span of 6-8 months, underscores the profound influence of a clean environment on healing. However, in today’s context, with unprecedented levels of air pollution plaguing our cities, such a miraculous recovery would be exceedingly difficult to replicate.

My personal experiences with TB offered me several insights into the challenges faced by patients. My own battle with drug-resistant TB in 2005-2006 shed light on the arduous journey of TB treatment. Enduring months of toxic medications and isolation resulted in a massive physical and emotional toll. Despite the challenges, my recovery reaffirmed the importance of early detection, proper nutrition, and access to quality healthcare.

Nutrition is a cornerstone in TB treatment, with insufficient intake of vital nutrients, notably proteins, posing a significant obstacle to recovery. Considering India’s enduring struggle with hunger and susceptibility to TB due to numerous stressors, implementing effective nutritional interventions becomes imperative.

The COVID-19 pandemic showed us that we need a robust public health infrastructure and proactive measures to combat infectious diseases. While significant progress has been made in TB management, challenges such as limited outreach and reliance on the private sector persist. Bridging the gap between public and private healthcare sectors is crucial to expanding access to TB treatment and prevention services.

The National Tuberculosis Treatment (NTTB) program in India predominantly operates within the private sector, with approximately 70% of TB treatments being conducted outside of government facilities. Despite the government funded schemes, there is a notable lack of outreach and funding, hindering efforts to combat TB effectively. Recognizing the need for a coordinated approach, I established the Global Coalition Against TB (G-CAT), leveraging support from parliamentarians across party lines to advocate for improved TB care and awareness.

To understand TB, it’s essential to grasp its causative agent, Mycobacterium tuberculosis. TB exists along a spectrum, ranging from latent to active infection. Latent TB, characterized by the absence of symptoms, affects a significant portion of the population. However, detecting latent TB remains a challenge, with estimates suggesting that up to 40-60% of India’s population may be affected.

 T cells play a crucial role in the body’s immune response against tuberculosis (TB), particularly in the context of latent TB infection. When an individual harbors latent TB, the mycobacterium tuberculosis bacillus is contained within granulomas, structures formed by the immune system to isolate the bacteria. T cells, a type of white blood cell, are instrumental in maintaining the stability of these granulomas and preventing the progression of latent TB to active disease.

TB – Skin Test

While active TB presents with symptoms such as coughing, diagnosing latent TB requires specialized tests, including the Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRA). Despite the availability of diagnostic tools, treating latent TB remains an underexplored area in India. Unlike countries like Canada, the USA, and Australia, where latent TB treatment is standard practice, India lags behind in implementing preventive measures.

Vaccination represents a promising avenue for TB prevention, yet progress in this area has been slow. Despite substantial investments in TB vaccine research, no viable candidate has emerged. Drawing parallels with the rapid development of COVID-19 vaccines, I advocate for leveraging the momentum and resources generated by the pandemic to accelerate TB vaccine development.

Drug-resistant tuberculosis (DR-TB) poses another significant challenge to TB control efforts globally, with India bearing the highest burden of DR-TB cases, particularly concentrated in cities like Mumbai. DR-TB refers to strains of the TB bacteria that are resistant to the standard first-line drugs used in TB treatment, namely isoniazid and rifampicin. These drug-resistant strains can emerge due to factors such as improper TB treatment, inadequate drug supply, and patient non-adherence to medication regimens.

The challenges in combating TB extend beyond diagnosis and treatment to include addressing missing cases and enhancing primary healthcare infrastructure. In India, millions of TB cases go unreported and untreated, perpetuating the cycle of transmission. Improving access to quality healthcare at the grassroots level is essential to reaching these underserved populations.

Despite the urgency of addressing TB, the global response lacks the same level of urgency seen during the COVID-19 pandemic. TB has historically received less attention and funding compared to diseases like HIV/AIDS, despite its ancient presence and substantial global burden. Stigma surrounding TB, coupled with limited awareness, has contributed to its neglect.

Nevertheless, significant improvements have been observed, instilling hope that we can effectively combat and ultimately eradicate the scourge of TB. The National TB Elimination Program (NTEP) has screened more than 80 million people for tuberculosis, successfully treated 15 million patients and saved millions of lives. Efforts have been made to raise awareness and destigmatize TB, including advocacy initiatives involving parliamentarians and policymakers. These efforts have been instrumental in driving policy changes, such as banning unreliable serological tests for TB diagnosis and implementing molecular diagnostics. Another major milestone in the TB eradication endeavor has been the substantial increase in TB notifications. This can be attributed, in part, to the integration of the private sector and the provision of nutritional support to TB patients. Another positive has been the recognizing the importance of proper nutrition in TB recovery, a monthly stipend of 500 rupees was instituted to alleviate financial constraints and improve treatment outcomes.

Collaborative efforts led by organizations such as the Global Fund, the Ministry of Health of the Government of India, and PATH have been pivotal in the fight against tuberculosis (TB). This joint initiative, initially launched in Patna and later expanded to Maharashtra and Gujarat, operates within a Public-Private Partnership (PPP) framework and has become a cornerstone of the National Tuberculosis Elimination Program (NTTB). Despite facing initial challenges, including logistical and administrative hurdles, the program gradually gained momentum, expanding its reach and impact across the country.

The emergence of the COVID-19 pandemic posed significant challenges to TB detection and treatment efforts. Fear and restrictions impeded access to healthcare services, resulting in a decline in TB diagnoses. To address this, innovative strategies such as bi-directional testing were implemented, ensuring that individuals undergoing COVID-19 screening were also assessed for TB. Leveraging existing community health infrastructure facilitated the delivery of essential medications directly to patients’ doorsteps, mitigating disruptions in TB care amidst the pandemic.

Additionally, the adoption of Information and Communication Technology (ICT) for monitoring and follow-up, inspired by successful models in countries like South Africa and Brazil, has enhanced program efficiency. This technological integration enables timely interventions and ensures continuity of care for TB patients, even amidst resource constraints and logistical challenges.

Looking ahead, sustained community engagement and multi-sectoral collaboration are paramount for achieving the ambitious goal of TB elimination by 2025. Leveraging the extensive network of local governments, civil society organizations, and influential personalities can bolster awareness and mobilize support for TB control efforts. Additionally, addressing social stigma associated with TB remains imperative, requiring concerted efforts to dispel myths and misconceptions surrounding the disease.